# Clinical Trial Comparing Single-administration of DA-5222 and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects in Fed State

> **NCT07046715** · PHASE1 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** DA-5222
- **DRUG:** DA-5222-R1
- **DRUG:** DA-5222-R2
- **DRUG:** DA-5222-R3

## Key facts

- **NCT ID:** NCT07046715
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-07
- **Primary completion:** 2025-08-19
- **Final completion:** 2025-08-19
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07046715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07046715, "Clinical Trial Comparing Single-administration of DA-5222 and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects in Fed State". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07046715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*